Taipei, Taiwan – August 28, 2025 – Taipei Medical University (TMU) highlighted major advancements in atrial fibrillation (AF) treatment at its 2025 Donor Appreciation and Award Ceremony. During the event, Dr. Chao-Shun Chan (詹超舜), Director of Cardiology at Taipei Medical University Hospital (TMUH), presented the hospital’s latest clinical achievements and outlined a forward-looking roadmap for the next phase of AF care.

Dr. Chao-Shun Chan thanked long-time donors for their support and introduced new milestones in atrial fibrillation treatment at the ceremony.

Dr. Chan expressed gratitude to the donors whose sustained support has enabled TMUH to introduce cutting-edge technologies and elevate the standard of AF treatment in Taiwan.
“Atrial fibrillation is one of the most common cardiac arrhythmias and, if left untreated, can significantly increase the risk of stroke,” said Dr. Chan. “Each new advancement reflects our donors’ commitment, making it possible for us to deliver world-class therapies to patients in Taiwan and beyond.”

Through generous contributions, TMUH has steadily expanded its treatment options:

• In 2019, backed by Chairman Ray-Jade Chen (陳瑞杰), TMUH introduced advanced radiofrequency ablation systems, completing more than 400 procedures to date.
• In 2021, with support from Chairperson Yong-Fen Hsieh (謝詠芬), the hospital acquired cryoballoon ablation technology, enabling over 100 successful cases.
• In 2025, thanks to Chairmen Kuang-Hui Liu (劉光輝) and Tsung-Lin Tseng (曾宗琳), TMUH became one of the first in Taiwan to adopt Pulsed Field Ablation (PFA), already achieving more than 30 cases with excellent outcomes.

In 2025, supported by Chairman Ray-Jade Chen, President Mai-Szu Wu (吳麥斯), and Superintendent Chun-Ming Shih (施俊明), TMUH’s third catheterization laboratory has been officially established, further enhancing clinical capacity.

Radiofrequency ablation for atrial fibrillation

Left and center: Cryoballoon ablation for atrial fibrillation. Right: Pulsed field ablation for atrial fibrillation.

Left: Live demonstration of pulsed field ablation for atrial fibrillation. Right: Ribbon-cutting ceremony for the completion of the third catheterization laboratory.

These milestones have benefited patients while establishing TMU as a leader in cardiac electrophysiology. The hospital’s cardiology team has been featured in leading medical journals, participated in live surgical demonstrations organized by the Taiwan Heart Rhythm Society, and engaged in academic exchanges with international experts.

Looking ahead, TMU reaffirmed its commitment to advancing cardiac care, pledging to integrate clinical practice with research over the next five years to further enhance arrhythmia treatment and build a healthcare environment that meets international standards.